Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SHBG | P04278 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.32 |
| ▸ | P2RX7 | Q99572 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6970474 | 0.98 | SHBG (0.33) | SHBGSMN1; SMN2 | |
| SCHEMBL6961340 | 0.91 | — | — | |
| SCHEMBL6963958 | 0.85 | SHBG (0.34) | SHBGSMN1; SMN2EPHX1 | |
| SCHEMBL6963719 | 0.81 | SHBG (0.39) | SHBGSMN1; SMN2EPHX1 | |
| SCHEMBL22244734 | 0.80 | ADH1A (0.42) | SHBGSMN1; SMN2EPHX1 | |
| SCHEMBL6971461 | 0.79 | SHBG (0.35) | SHBGSMN1; SMN2 | |
| SCHEMBL6974490 | 0.78 | SHBG (0.39) | SHBGSMN1; SMN2EPHX1 | |
| SCHEMBL6967311 | 0.77 | SHBG (0.30) | SHBG | |
| SCHEMBL6976250 | 0.77 | SHBG (0.30) | SHBG | |
| SCHEMBL6966593 | 0.76 | SHBG (0.35) | SHBGEPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0870765-B1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARM CO LTD (JP) | 2003-11-19 | — | — | EP | disclosed |
| US-5981557-A | HAVING IMPROVING EFFECTS ON THE DYSMOTILITY IN THE GASTROINTESTINAL TRACT | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-11-09 | — | — | US | disclosed |
| EP-0870765-A1 | AMINOTHIAZOLE DERIVATIVES, DRUG CONTAINING THE SAME AND INTERMEDIATE IN THE PRODUCTION OF THE COMPOUNDS | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-14 | — | — | EP | disclosed |